John E. Bishop

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Cambridge, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Michael Raab, Attorney-in-Fact for John Bishop
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John E. Bishop

Form 4 holding Chief Technical and Quality Officer

ARDELYX, INC.

Security class
Common Stock
Shares / value
336,845
Estimated value
$2,111,176
Report date
21 May 2026
Price
$6.27
Ownership
Direct
Form 4 holding Chief Technology Officer

Lyra Therapeutics, Inc.

Security class
Stock Options
Shares / value
200,000
Estimated value
Report date
30 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Technical and Quality Officer

ARDELYX, INC.

Security class
Stock Option (Right to Buy)
Shares / value
186,500
Estimated value
Report date
23 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding SVP, Chief Technology Officer

Forma Therapeutics Holdings, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
14 Oct 2022
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John E. Bishop

3 ARDX

ARDELYX, INC.

Report period
01 Aug 2025
Transactions
0
Transaction value
$0
Accepted by SEC
17 Oct 2025, 18:18
Role
Chief Technical Operations Officer Exhibit 24.1 - Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .